Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Philips CPAP Preservation Order Issued For Recalled Sleep Apnea Machines Court describes how Philips and users who decide not to return their sleep apnea devices should preserve recalled DreamStation machines January 21, 2022 Irvin Jackson Add Your Comments The U.S. District Judge presiding over all federal Philips CPAP lawsuits has approved an interim plan jointly proposed by the parties, which outlines how certain evidence from the recalled sleep apnea machines should be preserved for future use in the litigation. Millions of Philips DreamStation CPAP and BiPAP machines were recalled in June 2021, due to problems with a polyester-based (PE-PUR) sound abatement foam inside the sleep apnea devices, which was intended to reduce sounds and vibrations during use. The manufacturer now acknowledges that the CPAP foam degrades over time, and may release black particles or debris directly into the sleep apnea machine’s air pathways, exposing users to a number of toxic chemicals and gases. As a result of the serious health risks, owners of an estimated 15 million machines have been urged to immediately stop using the devices for sleep apnea or other non-life sustaining treatments, and thousands of individuals are now pursuing lawsuits over the Philips CPAP machines, indicating that they developed cancer, lung damage or other respiratory problems. Given common questions of fact and law raised in product liability and class action lawsuits over recalled sleep apnea machines filed throughout the federal court system, the litigation has been centralized before Senior U.S. District Judge Joy Flowers Conti in the Western District of Pennsylvania for coordinated discovery and pretrial proceedings, as part of a multidistrict litigation (MDL). In an order (PDF) issued on January 11, Judge Conti approved an interim Philips CPAP preservation plan, outlining certain steps that must be taken during recall repairs or for machines not returned to the manufacturer. Stay Up-to-Date About Philips CPAP Recall Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Philips CPAP recall lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Philips CPAP Recall Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Philips CPAP recall lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More In the wake of the recall, Philips has not provide replacement CPAP machines to all consumers or offered to immediately refund sleep apnea machines with the defective PE-PUR foams. However, a Philips CPAP repair program was announced in September 2021, which is estimated to take up to a year to complete. As part of the remediation plan, Philips plans to “rework” DreamStation CPAP machines returned, by replacing the blower boxes that contain the PE-PUR foam with blower boxes that contain a silicone-based foam. Under the order, these Philips CPAP machine repairs may continue, but the manufacturer must take photographs and preserve certain evidence, including any SD cards returned inside the device. Individuals pursuing claims against the manufacturer do have the option of electing to have their Philips DreamStation CPAP machine preserved, by submitting certain information on a preservation registry. For those machines received by the manufacturer, Philips has been directed not remediate the machine and take certain steps to preserve the device. To ensure a sufficient quantity of the recalled sleep apnea machines with the PE-PUR foam are available for inspection, testing and analysis during the litigation, Philips has been directed to preserve additional CPAP blower box assemblies, as well as SD cards or humidifiers from certain returned devices. In addition, an agreed-upon number of new, unused Philips CPAP machines will be preserved for potential examination and testing. Under the agreed plan, any user may choose to retain their CPAP machine, and will not be required to return the recalled sleep apnea machine to receive a replacement device. However, certain information must be submitted on the Preservation Registry so that the parties can track what DreamStation devices are not being returned for repairs. As part of the coordinated pretrial proceedings, it is expected that Judge Conti will establish a bellwether program where case-specific discovery will be conducted on a group of representative claims, which may then be eligible for early trial dates to help the parties gauge how juries are likely to respond to certain evidence and testimony that may be repeated throughout the litigation. However, if Philips CPAP settlements or another resolution is not reached during the pretrial proceedings, each individual case may later be remanded back to various U.S. District Courts nationwide for future trial dates. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: CPAP, CPAP Recall, Philips, Sleep Apnea More Philips CPAP Recall Lawsuit Stories Lawsuits Between Philips and SoClean Over CPAP Machine Problems To Be Trial Ready by July 2025 September 3, 2024 Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October July 11, 2024 Philips OmniLab Advanced+ Ventilator Recall Issued Over Loss of Therapy Risks July 1, 2024 1 Comments Robert October 6, 2022 Does it better serve a patient’s interest as a potential plaintiff to take samples and photograph evidence before returning their CPAP machines to Philips? CompanyThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit (Posted: 2 days ago) A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Indicates Depo-Provera Meningioma Lawsuits Should Be Preempted by Federal Law (02/03/2026)Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (01/23/2026)Lawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026) MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide (Posted: 3 days ago) A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims. MORE ABOUT: DUPIXENT LAWSUITLawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL (02/10/2026)CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks (02/03/2026)Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (01/12/2026) $7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits (Posted: 4 days ago) Bayer and Monsanto say they have reached a $7.25 billion Roundup cancer lawsuit settlement resolving more than 100,000 claims as well as any future litigation that may be filed. MORE ABOUT: ROUNDUP LAWSUITSRoundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge (02/09/2026)Future of Roundup Lawsuits Over Non-Hodgkin’s Lymphoma To Be Decided by U.S. Supreme Court (01/19/2026)Roundup Safety Study Retracted Decades After Publication (12/08/2025)
Lawsuits Between Philips and SoClean Over CPAP Machine Problems To Be Trial Ready by July 2025 September 3, 2024
Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit (Posted: 2 days ago) A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Indicates Depo-Provera Meningioma Lawsuits Should Be Preempted by Federal Law (02/03/2026)Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (01/23/2026)Lawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026)
MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide (Posted: 3 days ago) A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims. MORE ABOUT: DUPIXENT LAWSUITLawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL (02/10/2026)CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks (02/03/2026)Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (01/12/2026)
$7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits (Posted: 4 days ago) Bayer and Monsanto say they have reached a $7.25 billion Roundup cancer lawsuit settlement resolving more than 100,000 claims as well as any future litigation that may be filed. MORE ABOUT: ROUNDUP LAWSUITSRoundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge (02/09/2026)Future of Roundup Lawsuits Over Non-Hodgkin’s Lymphoma To Be Decided by U.S. Supreme Court (01/19/2026)Roundup Safety Study Retracted Decades After Publication (12/08/2025)